Search clinical trials for: Risperidone and Ramelteon

Total 270723 results

Duke University
Janssen, LP

Completed

Determining the Effects of Risperdal Consta in Patients With Psychotic Disorders and Incomplete Adherence

Schizophrenia | Schizoaffective Disorder

United States
Janssen Pharmaceutica N.V., Belgium

Completed

A Pilot Study of the Use of Risperidone Long Acting Injectable in the Treatment of Patients With Recent Onset Psychosis

Schizophrenia
Janssen Pharmaceutica N.V., Belgium

Completed

A Study of Treatment Success in Changing From Olanzapine to Long-acting Injectable Risperidone (RISPERDAL® CONSTA™)

Psychotic Disorders | Schizophrenia
Johnson & Johnson Pharmaceutical Research & Development...
Janssen, LP

Completed

Study Comparing Risperidone vs Placebo as add-on Therapy in Patients With Generalized Anxiety Disorder Who Are Sub-optimally Responding to Standard Therapy.

Anxiety Disorders
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Manic or Mixed Episodes Associated With Bipolar I Disorder

Bipolar Disorder | Manic Episode
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Manic Episodes Associated With Bipolar I Disorder

Bipolar Disorders | Manic Episode
Janssen, LP

Completed

A Study Comparing Three Strategies to Switch Patients With Schizophrenia or Schizoaffective Disorder to Risperidone After Unsuccessful Treatment With Olanzapine.

Schizophrenia | Schizoaffective Disorder
Central Institute of Mental Health, Mannheim

Completed

Clozapine-Augmentation With Ziprasidone or Risperidone, a Randomized, Prospective Trial

Schizophrenia, Schizoaffective Disorder

Germany
Johns Hopkins University
National Institute on Aging (NIA)

Completed

Ramelteon in the Prevention of Post-operative Delirium (RECOVER)

Delirium | Delayed Emergence From Anesthesia | Delirium, Dementia, Amnestic, Cognitive Disorders | Cognitive Disorders

United States
Indivior Inc.

Completed

Safety, Tolerability, Pharmacokinetics and Efficacy of 180 mg Subcutaneous Risperidone From 6 mg Oral Risperidone

Schizophrenia

United States
Birte Glenthoj
Icahn School of Medicine at Mount Sinai

Terminated

The Effect of Sertindole and Risperidone on Endophenotypic Markers of Schizophrenia

Schizophrenia

Denmark
ValiSeek Limited

Completed

A Study of VAL401 in the Treatment of Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer

Adenocarcinoma | Carcinoma, Non-Small-Cell Lung
Indivior Inc.

Completed

Long Term Study of RBP 7000 in the Treatment of Subjects With Schizophrenia

Schizophrenia

United States
Rovi Pharmaceuticals Laboratories

Completed

Pharmacokinetics and Tolerability Study of Risperidone ISM® in Schizophrenia (PRISMA-2)

Schizophrenia

United States
Indivior Inc.

Completed

Single Ascending Dose Study of RBP-7000

Schizophrenia

United States
Janssen Korea, Ltd., Korea

Completed

An Efficacy and Safety Study of Long-Term Risperidone Microspheres in Participants With Schizophrenia

Schizophrenia | Schizoaffective Disorder

Korea, Republic of
Janssen Pharmaceutica N.V., Belgium

Completed

A Study of Risperidone in Combination With Lorazepam Compared With Standard Therapy for Emergency Treatment of Schizophrenic Patients

Psychotic Disorders | Schizophrenia | Emergency Treatment
AstraZeneca

Completed

Safety and Efficacy of Seroquel in First Episode Schizophrenia

Schizophrenia

United Kingdom
Rovi Pharmaceuticals Laboratories

Completed

Comparative Bioavailability of Risperidone

Schizophrenia

United States
Indivior Inc.

Completed

Multiple Ascending Dose Study of the Safety, Tolerability, Pharmacokinetic/Efficacy

Schizophrenia

United States
Janssen-Cilag Ltd.

Completed

Switching From Oral Antipsychotics to Long-Acting Risperidone in Participants With Schizophrenia

Schizophrenia

Brazil
Janssen Pharmaceutica N.V., Belgium

Completed

A Study of the Safety and Effectiveness of Risperidone for the Treatment of Conduct Disorder and Other Disruptive Behavior Disorders in Children Ages 5 to 12 With Mild, Moderate, or Borderline Mental Retardation

Conduct Disorder | Oppositional Defiant Disorder | Disruptive Behavior Disorder
Hospital Authority, Hong Kong
Janssen Pharmaceutica N.V., Belgium

Unknown

Evaluation of Efficacy and Safety of Long-acting Risperidone Microspheres in Patients With Schizophrenia or Other Psychotic Disorders When Switching From Typical Antipsychotic (Oral/Depot) or Atypical Oral Other Than Risperidone

Psychotic Disorders | Schizophrenia | Schizophrenia, Paranoid | Schizophrenia, Catatonic | Schizophrenia, Disorganized

China
Erasmus Medical Center
ZonMw: The Netherlands Organisation for Health Research and Development; Stichting...

Recruiting

Safety and Pharmacokinetics of Antipsychotics in Children 2: Studying TDM in an RCT (SPACe2:STAR)

Autism Spectrum Disorder

Netherlands
Janssen, LP

Completed

Observational Study in Patients With Schizophrenia Treated With Long-Acting Risperidone Injection (RISPERDAL CONSTA) (SOURCE)

Schizophrenia

United States
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Comparison of the Pharmacokinetics and Safety of Long-acting Injectable Risperidone When Administered to Gluteal or Deltoid Intramuscular Injection Sites in Stable Schizophrenia Patients.

Schizophrenia
Janssen Pharmaceutica N.V., Belgium

Completed

RiSPECT: Risperdal Safety Protocol Evaluation Consta Treatment, a Post Authorization Safety Survey to Obtain Information on the Safety and Efficacy of Risperidone When Used in Routine Clinical Practice

Psychotic Disorders | Schizophrenia | Schizoaffective Disorder
Indivior Inc.

Completed

Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients

Schizophrenia

United States
US Department of Veterans Affairs

Completed

Long-Acting Injectable Risperidone in the Treatment of Schizophrenia

Schizophrenia | Schizoaffective Disorder

United States
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Pharmacokinetic Study of Risperidone and Topiramate Administered Alone and in Combination in Patients With Bipolar Disorder or Schizoaffective Disorders

Bipolar Disorder
Janssen, LP

Completed

A Study of the Effectiveness and Safety of Risperidone Compared With Haloperidol in Patients With Chronic Schizophrenia

Schizophrenia | Psychotic Disorder
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study of the Effectiveness and Safety of Risperidone as add-on Therapy to Mood Stabilizers in the Treatment of Manic Episodes Associated With Bipolar Disorder

Bipolar Disorders | Manic Disorder
Rush University Medical Center
Janssen, LP

Terminated

Treatment of Major Depressive Disorder With Psychotic Features.

Major Depression With Psychotic Features

United States
Rovi Pharmaceuticals Laboratories

Completed

Comparative Bioavailability of Risperidone.

Schizophrenia

United States
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study of the Effectiveness and Safety of Risperidone Compared With Placebo in the Treatment of Manic Episodes Associated With Bipolar I Disorder, and the Maintenance of Anti-manic Effectiveness of Risperidone Compared With Haloperidol

Bipolar Disorders | Manic Disorder
Kaohsiung Kai-Suan Psychiatric Hospital

Terminated

Comparison of the Efficacy and Safety of Risperidone Versus Risperidone Plus Low Dose of Haloperidol in the Treatment of Schizophrenia

Schizophrenia

Taiwan
Inje University

Terminated

Quality of Life (QOL) in Female Patient With Schizophrenia

Schizophrenia

Korea, Republic of
Seattle Institute for Biomedical and Clinical Research
Janssen, LP

Completed

A Trial of Long-Acting Injectable Risperidone in the Treatment of Methamphetamine Dependence

Methamphetamine Dependence

United States
Northwell Health
National Alliance for Research on Schizophrenia and Depression; The Zucker...

Terminated

Optimizing Response in Psychosis Study (ORP)

Schizophrenia | Schizoaffective Disorder | Schizophreniform Disorder | Psychotic Disorder Not Otherwise Specified

United States
IPCA Laboratories Ltd.

Completed

Bioequivalence Study of Risperidone Tablet 1 mg Under Fasting Condition

Fasting

India
IPCA Laboratories Ltd.

Completed

Bioequivalence Study of Risperidone Tablet 1 mg Under Fed Condition

Fed

India
Johnson & Johnson Pharmaceutical Research & Development...
Janssen, LP

Completed

Efficacy and Safety of Two Atypical Antipsychotics vs. Placebo in Patients With an Acute Exacerbation of Either Schizophrenia or Schizoaffective Disorder

Schizophrenia | Schizoaffective Disorder

United States, India, Romania
Birte Glenthoj
Rigshospitalet, Denmark; University of Copenhagen; Hvidovre University Hospital; The Novo Nordic Foundation and other collaborators

Completed

Dopaminergic, Functional, Structural, and Cognitive Disturbances in First-episode Schizophrenia

Schizophrenia

Denmark
Janssen, LP

Completed

A Study of the Effectiveness and Safety of Risperidone Compared With Haloperidol and Placebo in Patients With Chronic Schizophrenia

Psychotic Disorders | Schizophrenia
Janssen Pharmaceutica N.V., Belgium

Completed

A Study of the Effectiveness and Safety of Risperidone in the Treatment of Behavioral Disturbances in Patients With Dementia

Dementia | Alzheimer Disease | Dementia, Vascular
University of Connecticut
Janssen Pharmaceutica N.V., Belgium

Terminated

Haloperidol vs. Risperidone in the Treatment of Aggression in Psychotic Inmates

Aggression | Psychosis

United States
University of Manchester
King's College London; Cardiff University; P1vital Limited

Completed

Effects of Ketamine and Risperidone on Cognition (Schiz_2)

Schizophrenia | Healthy Volunteers

United Kingdom
Dartmouth-Hitchcock Medical Center
National Institute of Mental Health (NIMH)

Completed

First Episode Schizophrenia and Cannabis-Related Disorder Study

Substance-Related Disorders | Psychotic Disorders | Schizophrenia | Cannabis-Related Disorder

United States
Merck Sharp & Dohme LLC

Completed

An Active-Controlled Early Phase Study of MK-8189 in Adults With Schizophrenia (MK-8189-005)

Schizophrenia, Acute Episode

United States
AstraZeneca

Completed

A Comparison of Seroquel vs. Risperidone in Schizophrenia

Schizophrenia

United States

3

Subscribe